Natera

Incyte

United Therapeutics

Gilead Sciences

Insmed

Neurocrine Biosciences

Vertex Pharmaceuticals

Alnylam Pharmaceuticals

AbbVie

Sarepta Therapeutics

SPDR S&P Biotech ETF

XBI tracks an equal-weighted index of US biotechnology stocks.

First Trust Financials AlphaDEX Fund

US Global Jets ETF

Global X Superdividend ETF

Vanguard Extended Market ETF

Wall Street has been wavering in recent sessions due to renewed virus fears, higher inflation and rising rate worries.

5 ETFs to Offer a Really Good Deal on Black Friday

Amgen

VanEck Vectors Biotech ETF

Biogen

iShares Nasdaq Biotechnology ETF

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

How Are Biotech ETFs Reacting to These Q3 Earnings Releases?

Principal Healthcare Innovators Index ETF

First Trust NYSE Arca Biotechnology Index Fund

In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.

Can Biotech ETFs Gain From Positive Booster Update?

iShares Core U.S. Aggregate Bond ETF

ARK Innovation ETF

Amplify Online Retail ETF

iShares Core MSCI EAFE ETF

iShares Russell 3000 ETF

Schwab U.S. Broad Market ETF

SPDR S&P 500 ETF Trust

Vanguard Total Stock Market ETF

Building a core satellite ETF portfolio can give investors the best of two worlds.

ETFs All You Need For Portfolios

iShares Currency Hedged MSCI Japan ETF

Vanguard High Dividend Yield ETF

Materials Select Sector SPDR Fund

Some market watchers are raising concerns about overvaluation in the market. Investors can thus bet on these undervalued but top-ranked ETFs.

Stocks to Correct 5-10% in 2021? Buy These ETFs

SPDR Dow Jones Industrial Average ETF

VanEck Vectors Israel ETF

Schwab U.S. Small-Cap ETF

The S&P 500 has been in a great shape this year, calling for overvaluation concerns. Why not investing in ETFs that have underperformed the S&P 500, have a lower P/E and have a Buy rating.

5 Top ETFs With Great Value & More Room for Growth

XBI has recently closed above its 10 month moving average, indicating a buy signal.

XBI Now Offers An Excellent Long-Term Entry Point

Global X Telemedicine & Digital Health ETF

Global X Education ETF

iShares S&P 500 Value ETF

iShares U.S. Technology ETF

Vanguard Mega Cap Value ETF

Vanguard Information Technology ETF

Direxion Work From Home ETF

Technology Select Sector SPDR Fund

Let's take a look at some ETF areas that can be good investment options for September.

Best ETF Areas for Placing Your Bets in September

Amplify Treatments Testing & Advancements ETF

Pacer BioThreat ETF

ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.

COVID Biotech ETFs Rise At Fever Pace

Virtus LifeSci Biotech Clinical Trials ETF

Loncar Cancer Immunotherapy ETF

Defiance Nasdaq Junior Biotechnology ETF

Pfizer

ALPS Medical Breakthroughs ETF

Trillium Therapeutics

The FDA granted full approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech that could accelerate inoculations in the United States.

Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News

Biotech ETFs shot higher after the FDA formally approved Pfizer's vaccine. Trade the group's two largest funds with these tactical ideas.

Hopes of Moderna (MRNA) Vaccine Approval Boost Biotech

While the world's leading biotech companies — churning out Covid-19 vaccines and treatments — have hit record share prices, their.

Small-Cap Biotech Stocks Are Having a Rough Year, But That Could Change in a Heartbeat

The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

Biotech ETFs to Benefit From Latest Booster Update

How Are Biotech ETFs Reacting to These Q2 Earnings Releases?

I am long-term bullish on American innovation and the biotech sector.

XBI And Leveraged Model Portfolio

eBay

Novavax

Even at all time high indices there are stocks to buy. Today we find three swing trade opportunities while the bulls are in charge.

3 Stocks to Buy for the Second Half of 2021

iShares Select Dividend ETF

ProShares S&P 500 Dividend Aristocrats ETF

First Trust NASDAQ-100 Technology Sector Index Fund

SPDR S&P Dividend ETF

Vanguard Dividend Appreciation ETF

Let's take a look at some ETF areas that can be good investment options for August.

ETF Investing Areas to Consider for August

The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.

Delta Variant Surge Brings Biotech ETFs in Focus

The ETF's share price has been trailing the broader market as well as a peer for the last one year.

XBI: Portfolio Changes Offers Better Protection Against Volatility

ARK Genomic Revolution Multi-Sector ETF

iShares Genomics Immunology and Healthcare ETF

Invesco Dynamic Biotechnology & Genome ETF

Biotechnology is a dynamic but often volatile industry. These biotech ETFs provide a lower-risk way to invest in the space.

9 Best Biotech ETFs to Play High-Octane Trends

The SPDR S&P Biotech ETF (NYSE: XBI) is trading below an important resistance level, but the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) has broken out. Resistance is a large group of sellers who are all trying to sell their shares at the same price.

IBB Vs. XBI: Which Biotech ETF Has A Better Chart?

Biotech stocks are rallying this month; can the trend continue?

Should You Buy Biotech ETFs Now?

The FDA approval of Biogen's "Aduhelm" to treat Alzheimer's disease could open the door for other experimental drugs to move forward through clinical trials.

XBI: Alzheimer's Drug Approval Supports Renewed Bullish Industry Sentiment

XBI: Long American Innovation

Global X Genomics & Biotechnology ETF

iShares MSCI India ETF

In a sector where picking individual stocks is a high-risk, high-reward strategy, the diversification of exchange-traded funds can be highly appealing.

News for SPDR S&P Biotech ETF ETF (XBI)